Ulcerative Colitis
📧 Sign up to get email alerts when something new happens for Ulcerative Colitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis [Phase 2]
A phase 2 trial of BI 3032950 for ulcerative colitis is ongoing, and the study is currently not recruiting.
-
CLINICAL_TRIALS trial_result · 2026-03-05Clinical Trial Update: Rehabilitation After Ileo-anal Pouch Surgery [NA]
A completed clinical trial update on rehabilitation after ileo-anal pouch surgery, examining physical therapy modalities and biofeedback.
-
CLINICAL_TRIALS trial_result · 2026-03-05Clinical Trial Update: Impact of the Novel UC-TREAT Diet on the Gut Microbiome and Its Acceptability in Healthy Adults and Adults With Quiescent Ulcerative Colitis [NA]
The UC-TREAT diet trial evaluated its effects on the gut microbiome and acceptance in healthy adults and adults with quiescent ulcerative co…
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: A Study for HSK47388 in Participants With Ulcerative Colitis [Phase 2]
A Phase 2 clinical trial evaluating HSK47388 for ulcerative colitis is currently recruiting, sponsored by Haisco Pharmaceutical Group Co., L…
-
EMA approval · 2026-03-03EMA Authorised: Zeposia (ozanimod hydrochloride) — Bristol-Myers Squibb Pharma EEIG
The EMA has authorised Zeposia (ozanimod hydrochloride) for relapsing-remitting multiple sclerosis and ulcerative colitis; the marketing aut…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
EMA approval · 2026-03-03EMA Authorised: Entyvio (vedolizumab) — Takeda Pharma A/S
The European Medicines Agency authorised Entyvio (vedolizumab) for the treatment of ulcerative colitis and Crohn's disease, with Takeda Phar…
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: A Study of Mirikizumab (LY3074828) in Pediatric Participants With Moderately to Severely or Active Ulcerative Colitis [Phase 3]
Phase 3 pediatric trial evaluating mirikizumab for moderately to severely active ulcerative colitis is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: Real-World Effectiveness and Safety of Upadacitinib Plus Vedolizumab vs Upadacitinib Monotherapy During Induction in Moderate-to-Severe Ulcerative Colitis
This document outlines a real-world study comparing the effectiveness and safety of combining upadacitinib with vedolizumab versus upadaciti…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Autologous CAR-T Cell Therapy for Refractory and Relapsing Ulcerative Colitis: A Single-Center Exploratory Study [EARLY_Phase 1]
This document describes a single-center Phase 1 exploratory study evaluating autologous CAR-T cell therapy for refractory or relapsing ulcer…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Impact of Prebiotics in Ulcerative Colitis [NA]
A UCLA-sponsored clinical trial is investigating the impact of prebiotics in ulcerative colitis, with Crohn's disease also listed; the study…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Health-Related Quality of Life Among Patients With Inflammatory Bowel Disease
A Cairo University-sponsored clinical trial update on health-related quality of life in inflammatory bowel disease, including ulcerative col…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Fermented Food-Supplemented Diet in Ulcerative Colitis [NA]
Stanford University is sponsoring a clinical trial to evaluate a fermented food–supplemented diet for ulcerative colitis, and the study is c…
-
CLINICAL_TRIALS trial_result · 2026-02-27Clinical Trial Update: Expanded Access to Vedolizumab for Children and Teenagers With Ulcerative Colitis or Crohn's Disease in the USA
Takeda is providing expanded access to vedolizumab for children and teenagers with Crohn's disease or ulcerative colitis in the United State…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: A Mindfulness-based Stress Reduction Program for IBD [NA]
This clinical trial update describes a mindfulness-based stress reduction program being studied for inflammatory bowel disease, including Cr…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: The Influence of a Fasting Mimicking Diet on Ulcerative Colitis [NA]
Stanford University is conducting a trial to evaluate whether a fasting-mimicking diet can influence disease activity in ulcerative colitis,…
-
FDA approval · 2026-02-25FDA Approved: ENTYVIO — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approved a supplemental application for ENTYVIO (vedolizumab) submitted by Takeda Pharmaceuticals America, Inc., to support an expanded …
-
EMA approval · 2026-02-25EMA Authorised: Gotenfia (golimumab) — Stada Arzneimittel AG
The EMA authorised Gotenfia (golimumab) by Stada Arzneimittel AG for multiple inflammatory diseases, including rheumatoid arthritis, juvenil…
-
CLINICAL_TRIALS trial_result · 2026-02-25Clinical Trial Update: Determine PK Profiles of Ozanimod and Its' Major Metabolites in Healthy Subjects
This completed clinical trial evaluated the pharmacokinetics of ozanimod and its major metabolites in healthy subjects to characterize expos…
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: Partial Enteral Nutrition to Prevent Weight Loss and Sarcopenia in IBD Patients at Nutritional Risk - SIMBA [NA]
A clinical trial registry entry for a partial enteral nutrition approach aimed at preventing weight loss and sarcopenia in inflammatory bowe…
-
CLINICAL_TRIALS trial_result · 2026-02-25Clinical Trial Update: A Study to Learn About the Safety, Effects and Pharmacokinetics of Study Medication (PF-07054894) for the Treatment of Ulcerative Colitis [Phase 1]
Phase 1 study to assess safety, pharmacokinetics, and effects of PF-07054894 in ulcerative colitis; the trial was terminated.
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: Evaluation of Oral Tofacitinib in Children Aged 2 to 17 Years Old Suffering From Moderate to Severe Ulcerative Colitis [Phase 3]
Pfizer is evaluating oral tofacitinib in a Phase 3 trial for children aged 2 to 17 with moderate to severe ulcerative colitis; the study is …
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: A Study in Adults With Inflammatory Bowel Disease (IBD) Receiving Vedolizumab in the Patient Support Program (PSP) in Brazil
Clinical trial update for adults with inflammatory bowel disease receiving Vedolizumab in a patient support program in Brazil; study status …
-
CLINICAL_TRIALS trial_result · 2026-02-24Clinical Trial Update: A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Vixarelimab in Participants With Moderate to Severe Ulcerative Colitis (UC) [Phase 2]
A Phase 2 trial of vixarelimab for moderate-to-severe ulcerative colitis was terminated, with the study results posted on February 24, 2026.
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: A Novel Remote Patient and Medication Monitoring Solution to Improve Adherence and PerSiStence With IBD Therapy [NA]
This clinical trial update describes a remote patient and medication monitoring solution designed to improve adherence and persistence with …
-
CLINICAL_TRIALS trial_result · 2026-02-23Clinical Trial Update: A Study of PALI-2108 in Healthy Volunteers, Patients With Ulcerative Colitis, and Patients With Fibrostenosing Crohn's Disease [Phase 1]
Phase 1 study of PALI-2108 in healthy volunteers and patients with ulcerative colitis or fibrostenosing Crohn's disease is active but not re…